title: Acute retinal necrosis secondary to cytomegalovirus following successful treatment of cytomegalovirus anterior uveitis in an immunocompetent adult.
authors.forename: Chris
authors.initials: C
authors.lastname: Or
authors.forename: Natasha
authors.initials: N
authors.lastname: Press
authors.forename: Farzin
authors.initials: F
authors.lastname: Forooghian
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use; D001082:Aqueous Humor / Q000821:virology; D003587:Cytomegalovirus / Q000235:genetics / Q000302:isolation & purification; D003586:Cytomegalovirus Infections / Q000188:drug therapy* / Q000821:virology; D004279:DNA, Viral / Q000235:genetics; D004359:Drug Therapy, Combination; D015828:Eye Infections, Viral / Q000188:drug therapy* / Q000821:virology; D017245:Foscarnet / Q000627:therapeutic use; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007121:Immunocompetence; D058449:Intravitreal Injections; D008297:Male; D008875:Middle Aged; D016133:Polymerase Chain Reaction; D015882:Retinal Necrosis Syndrome, Acute / Q000175:diagnosis / Q000188:drug therapy / Q000821:virology*; D014222:Triamcinolone Acetonide / Q000627:therapeutic use; D014606:Uveitis, Anterior / Q000188:drug therapy* / Q000821:virology; D014792:Visual Acuity / Q000502:physiology
chemical_list: D000998:Antiviral Agents; D004279:DNA, Viral; D005938:Glucocorticoids; D017245:Foscarnet; D014222:Triamcinolone Acetonide